1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Hsu, S.-T. Breukink, E. Bierbaum, G. Sahl, H.-G. de Kruijff, B. Kaptein, R. van Nuland, N.A. Bonvin, A.M. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C4 H9 N O2 103.120 D-ALPHA-AMINOBUTYRIC ACID D-peptide linking C3 H5 N O2 87.077 n 2-AMINO-ACRYLIC ACID 2,3-DIDEHYDROALANINE peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C2 H5 N S 75.133 2-AMINO-ETHENETHIOL 2-THIOETHENAMINE non-polymer C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 278 13110 10.1074/JBC.M211144200 12562773 NMR Study of Mersacidin and Lipid II Interaction in Dodecylphosphocholine Micelles. Conformational Changes are a Key to Antimicrobial Activity 2003 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M x-ray 1 1.0 1834.256 LANTIBIOTIC MERSACIDIN 1 nat polymer TYPE-B LANTIBIOTICS MERSACIDIN no yes C(DBB)F(DBB)LPGGGGVC(DBB)L(DBB)(DHA)ECI(TEE) CTFTLPGGGGVCTLTSECIX A polypeptide(L) n n n n n n n n n n n n n n n n n n n n sample 69002 BACILLUS SP. HIL-Y85/54728 HIL Y-85, 54728 pdbx_database_related pdbx_nmr_ensemble pdbx_nmr_sample_details pdbx_nmr_software pdbx_nmr_spectrometer pdbx_struct_assembly pdbx_struct_assembly_prop pdbx_struct_oper_list repository Initial release Version format compliance Atomic model Database references Derived calculations Non-polymer description Structure summary Version format compliance Other Other Data collection Database references Derived calculations Experimental preparation 1 0 2003-03-11 1 1 2009-02-24 1 2 2011-07-13 1 3 2011-07-27 1 4 2012-12-12 1 5 2018-08-08 _pdbx_nmr_ensemble.conformer_selection_criteria _pdbx_nmr_ensemble.conformers_calculated_total_number _pdbx_nmr_sample_details.contents _pdbx_nmr_sample_details.label _pdbx_nmr_sample_details.solvent_system _pdbx_nmr_sample_details.type _pdbx_nmr_software.classification _pdbx_nmr_software.name _pdbx_nmr_software.version _pdbx_struct_assembly.details _pdbx_struct_assembly.method_details _pdbx_struct_oper_list.symmetry_operation SOLUTION STRUCTURE OF THE LANTIBIOTIC ACTAGARDINE SOLUTION STRUCTURE OF TYPE B LANTIBIOTICS MERSACIDIN IN MEOH/H2O MIXTURE SOLUTION STRUCTURE OF TYPE B LANTIBIOTICS MERSACIDIN IN DPC MICELLES CRYSTAL STRUCTURE OF THE TUPE B LANTIBIOTIC MERSACIDIN SOLUTION STRUCTURE OF THE LANTIBIOTIC EPILANCIN 15X SOLUTION STRUCTURE OF NISIN AND LIPID II COMPLEX SOLUTION STRUCTURE OF THE LANTIBIOTIC CINNAMYCIN COMPLEXED WITH LYSOPHOSPHATIDYLETHANOLAMINE SOLUTION STRUCTURE OF LCH-ALPHA PEPTIDE FROM TWO-COMPONENT LANTIBIOTIC SYSTEM LICHENICIDIN VK21 A1 SOLUTION STRUCTURE OF LCH-BETA PEPTIDE FROM TWO-COMPONENT LANTIBIOTIC LICHENICIDIN VK21 A2 Chemical shift data of mersacidin in MeOH/H2O chemical shift data of mersacidin DPCbound Chemical shift data of mersacidin in lipid II RCSB Y RCSB 2002-09-17 REL REL MERSACIDIN IS A GLOBULAR TYPE B LANTIBIOTIC. THE LANTIBIOTICS ARE CHARACTERIZED BY THIOETHER AMINO ACIDS LANTHIONINE AND/OR METHYLLANTHIONINE. HERE, MERSACIDIN IS REPRESENTED BY THE SEQUENCE (SEQRES) Antibiotic MERSACIDIN IS A TETRACYCLIC PEPTIDE. POST TRANSLATIONAL MATURATION OF LANTIBIOTICS INVOLVES THE ENZYMIC CONVERSION OF THR, AND SER INTO DEHYDRATED AA AND THE FORMATION OF THIOETHER BONDS WITH CYSTEINE. THE CARBOXY-TERMINAL BETA-METHYLLANTHIONINE UNDERGOES DECARBOXYLATION. THIOETHER BONDS WITH CYSTEINE RESULT IN FOUR RINGS. THIS IS FOLLOWED BY MEMBRANE TRANSLOCATION AND CLEAVAGE OF THE MODIFIED PRECURSOR. Mersacidin Oligopeptide structures with the lowest energy 50 17 2D NOESY 2D TOCSY DQF-COSY 6.0 1 atm 293 K OPLS WATER REFINEMENT SIMULATED ANNEALING TORSION, ANGLE DYNAMICS 2 mM mersacidin in 10 mM sodium phosphate buffer at pH 6.0, 2mM unlabeled lipid II, 100mM perdeuterated DPC, 37% methanol/63% H2O sample_1 37% methanol/63% H2O micelle refinement ARIA 1.1 collection XWINNMR processing NMRPIPE structure calculation CNS 1.1 structure calculation ARIA 1.1 500 Varian UNITYPLUS 600 Bruker DRX 750 Bruker DRX CYS 1 n 1 CYS 1 A DBB 2 n 2 DBB 2 A PHE 3 n 3 PHE 3 A DBB 4 n 4 DBB 4 A LEU 5 n 5 LEU 5 A PRO 6 n 6 PRO 6 A GLY 7 n 7 GLY 7 A GLY 8 n 8 GLY 8 A GLY 9 n 9 GLY 9 A GLY 10 n 10 GLY 10 A VAL 11 n 11 VAL 11 A CYS 12 n 12 CYS 12 A DBB 13 n 13 DBB 13 A LEU 14 n 14 LEU 14 A DBB 15 n 15 DBB 15 A DHA 16 n 16 DHA 16 A GLU 17 n 17 GLU 17 A CYS 18 n 18 CYS 18 A ILE 19 n 19 ILE 19 A TEE 20 n 20 TEE 20 A author_defined_assembly 1 monomeric 210 -2 1560 A DBB 2 POST-TRANSLATIONAL MODIFICATION A DBB 2 THR A DBB 4 POST-TRANSLATIONAL MODIFICATION A DBB 4 THR A DBB 13 POST-TRANSLATIONAL MODIFICATION A DBB 13 THR A DBB 15 POST-TRANSLATIONAL MODIFICATION A DBB 15 THR A DHA 16 POST-TRANSLATIONAL MODIFICATION A DHA 16 SER A TEE 20 POST-TRANSLATIONAL MODIFICATION A TEE 20 CYS 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 1 A A HB2 SG DBB CYS 4 12 1.02 1 A A HB2 SG DBB TEE 15 20 1.15 2 A A CG SG DBB CYS 13 18 1.85 3 A A HB2 SG DBB TEE 15 20 1.07 3 A A HB2 SG DBB CYS 4 12 1.27 3 A A CG SG DBB CYS 4 12 1.89 3 A A CG SG DBB CYS 13 18 2.03 4 A A HB2 SG DBB CYS 4 12 1.12 4 A A CG SG DBB CYS 4 12 2.06 4 A A CG SG DBB CYS 13 18 2.11 5 A A HB2 SG DBB CYS 4 12 1.22 5 A A CG SG DBB CYS 13 18 1.73 5 A A CG SG DBB CYS 4 12 1.95 6 A A HB2 SG DBB TEE 15 20 1.06 6 A A HB2 SG DBB CYS 4 12 1.20 6 A A CG SG DBB CYS 13 18 1.94 6 A A CG SG DBB CYS 4 12 2.02 7 A A HB2 SG DBB CYS 4 12 0.87 7 A A CG SG DBB CYS 13 18 2.02 8 A A HB2 SG DBB TEE 15 20 1.17 8 A A HB2 SG DBB CYS 4 12 1.33 8 A A CG SG DBB CYS 13 18 1.82 9 A A HB2 SG DBB TEE 15 20 0.99 9 A A HB2 SG DBB CYS 4 12 1.19 9 A A CG SG DBB CYS 13 18 1.80 9 A A CG SG DBB CYS 4 12 1.95 10 A A HB2 SG DBB TEE 15 20 1.09 10 A A SG CG CYS DBB 1 2 1.51 10 A A SG HG1 CYS DBB 1 2 1.52 10 A A SG HG3 CYS DBB 1 2 1.52 10 A A CG SG DBB CYS 13 18 1.69 11 A A HB2 SG DBB TEE 15 20 1.05 11 A A HB2 HD3 LEU PRO 5 6 1.34 11 A A CG SG DBB CYS 13 18 1.90 12 A A HB2 SG DBB CYS 4 12 1.31 12 A A HD2 HB3 PHE CYS 3 18 1.31 12 A A CG SG DBB CYS 4 12 1.76 12 A A CG SG DBB CYS 13 18 1.85 13 A A CG SG DBB CYS 13 18 1.86 14 A A HB2 SG DBB TEE 15 20 1.15 14 A A HB2 SG DBB CYS 4 12 1.29 14 A A HA HB2 DBB CYS 13 18 1.32 14 A A CG SG DBB CYS 13 18 1.71 15 A A HD2 HB3 PHE CYS 3 18 1.35 15 A A HB2 SG DBB CYS 4 12 1.36 15 A A CG SG DBB CYS 4 12 1.72 15 A A CG SG DBB CYS 13 18 1.90 16 A A HB2 SG DBB CYS 4 12 0.93 16 A A CG SG DBB CYS 13 18 1.71 17 A A HB2 SG DBB CYS 4 12 0.78 17 A A HB2 SG DBB TEE 15 20 1.07 17 A A CG SG DBB CYS 13 18 1.83 1 A DBB 2 -72.55 -145.54 1 A PHE 3 -58.25 106.61 1 A DBB 4 151.99 125.46 1 A CYS 18 -138.37 -83.89 2 A DBB 2 -73.15 -150.17 2 A LEU 5 -175.62 -35.12 2 A PRO 6 -96.27 -159.97 2 A CYS 18 -141.74 -82.85 3 A DBB 2 -73.05 -146.13 3 A DBB 4 134.47 141.81 3 A LEU 5 -130.79 -54.71 3 A CYS 18 -131.75 -86.56 4 A DBB 2 -69.54 158.71 4 A DBB 4 119.35 164.57 4 A LEU 5 -165.68 -38.44 4 A CYS 12 -67.11 99.37 4 A CYS 18 -136.67 -84.93 5 A DBB 2 -74.87 -147.37 5 A DBB 4 130.74 100.16 5 A CYS 18 -136.55 -87.39 6 A DBB 2 -71.82 -164.23 6 A DBB 4 128.72 98.65 6 A CYS 18 -134.58 -85.31 7 A DBB 2 176.15 -146.28 7 A LEU 5 -178.30 -36.87 7 A PRO 6 -91.97 -159.02 7 A VAL 11 -128.84 -88.48 7 A CYS 12 -173.84 81.23 7 A CYS 18 -132.79 -69.32 7 A ILE 19 -103.77 -77.33 8 A DBB 2 177.80 -143.62 8 A DBB 4 151.39 68.43 8 A PRO 6 -78.56 -168.69 8 A CYS 18 -131.77 -82.96 9 A DBB 2 -72.88 -147.40 9 A DBB 4 127.74 64.44 9 A CYS 18 -133.75 -86.21 10 A DBB 2 -177.98 -168.09 10 A PHE 3 -68.14 93.77 10 A DBB 4 146.25 101.13 10 A CYS 18 -144.52 -85.34 11 A DBB 2 -70.58 -154.22 11 A LEU 5 -137.10 -68.18 11 A CYS 12 78.87 120.41 11 A CYS 18 -142.91 -82.03 12 A DBB 2 173.11 -144.53 12 A DBB 4 112.53 155.85 12 A CYS 18 -136.86 -84.71 13 A DBB 2 -70.23 -151.24 13 A DBB 4 150.21 101.76 13 A CYS 18 -129.23 -86.34 13 A ILE 19 -68.12 -77.54 14 A DBB 2 -73.42 -147.68 14 A DBB 4 141.47 100.84 14 A PRO 6 -68.70 92.58 14 A CYS 18 -134.90 -87.82 15 A DBB 2 -72.65 -148.69 15 A DBB 4 128.82 140.68 15 A CYS 18 -143.40 -85.72 16 A DBB 2 -73.14 -148.43 16 A DBB 4 150.69 151.58 16 A CYS 18 -138.67 -83.88 17 A DBB 2 -74.73 -147.71 17 A DBB 4 151.01 150.52 17 A CYS 18 -143.79 -82.18 LANTIBIOTIC MERSACIDIN NMR solution structure of type-B lantibiotics mersacidin bound to lipid II in DPC micelles 1 N N covale 1.340 A CYS 1 A C CYS 1 1_555 A DBB 2 A N DBB 2 1_555 covale 1.807 A CYS 1 A SG CYS 1 1_555 A DBB 2 A CB DBB 2 1_555 covale 1.328 A DBB 2 A C DBB 2 1_555 A PHE 3 A N PHE 3 1_555 covale 1.323 A PHE 3 A C PHE 3 1_555 A DBB 4 A N DBB 4 1_555 covale 1.331 A DBB 4 A C DBB 4 1_555 A LEU 5 A N LEU 5 1_555 covale 1.810 A DBB 4 A CB DBB 4 1_555 A CYS 12 A SG CYS 12 1_555 covale 1.327 A CYS 12 A C CYS 12 1_555 A DBB 13 A N DBB 13 1_555 covale 1.803 A DBB 13 A CB DBB 13 1_555 A CYS 18 A SG CYS 18 1_555 covale 1.322 A DBB 13 A C DBB 13 1_555 A LEU 14 A N LEU 14 1_555 covale 1.327 A LEU 14 A C LEU 14 1_555 A DBB 15 A N DBB 15 1_555 covale 1.810 A DBB 15 A CB DBB 15 1_555 A TEE 20 A SG TEE 20 1_555 covale 1.334 A DBB 15 A C DBB 15 1_555 A DHA 16 A N DHA 16 1_555 covale 1.327 A DHA 16 A C DHA 16 1_555 A GLU 17 A N GLU 17 1_555 covale 1.327 A ILE 19 A C ILE 19 1_555 A TEE 20 A N TEE 20 1_555 ANTIBIOTIC ANTIBIOTIC, ANTIMICROBIAL, LANTIBIOTICS, BACTERIOCIN, PEPTIDOGLYCAN, METHICILLIN RESISTANCE, THIOESTER A CYS 1 A CYS 1 1 A DBB 2 A DBB 2 1.95 A CYS 1 A CYS 1 2 A DBB 2 A DBB 2 1.88 A CYS 1 A CYS 1 3 A DBB 2 A DBB 2 0.64 A CYS 1 A CYS 1 4 A DBB 2 A DBB 2 0.39 A CYS 1 A CYS 1 5 A DBB 2 A DBB 2 1.46 A CYS 1 A CYS 1 6 A DBB 2 A DBB 2 1.07 A CYS 1 A CYS 1 7 A DBB 2 A DBB 2 -1.75 A CYS 1 A CYS 1 8 A DBB 2 A DBB 2 -2.39 A CYS 1 A CYS 1 9 A DBB 2 A DBB 2 1.28 A CYS 1 A CYS 1 10 A DBB 2 A DBB 2 -3.46 A CYS 1 A CYS 1 11 A DBB 2 A DBB 2 4.13 A CYS 1 A CYS 1 12 A DBB 2 A DBB 2 -2.28 A CYS 1 A CYS 1 13 A DBB 2 A DBB 2 4.83 A CYS 1 A CYS 1 14 A DBB 2 A DBB 2 0.63 A CYS 1 A CYS 1 15 A DBB 2 A DBB 2 1.65 A CYS 1 A CYS 1 16 A DBB 2 A DBB 2 0.96 A CYS 1 A CYS 1 17 A DBB 2 A DBB 2 0.99 MRSA_BACSP UNP 1 P43683 49 68 1MQZ 1 20 P43683 A 1 1 20 1 P 1